Coen Stacy Ann
- SEC CIK
- 0001814150
No open-market purchases or sales filed in the past year.
Current role at each company
- FBLG FibroBiologics, Inc.Directoras of Jun 12, 2025
- IMGN ImmunoGen, Inc.SVP & CHIEF BUSINESS OFFICERas of Feb 12, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Coen Stacy Ann as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMGN ImmunoGen, Inc.
SVP & CHIEF BUSINESS OFFICER5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Coen Stacy AnnSVP & CHIEF BUSINESS OFFICER | SSale | −4.58K | $29.30 | −$134.3K | −5.9%73.3K after | 10b5-1 |
| Dec 5, 2023 (view filing) | Nov 30 | 5 daysLate | Coen Stacy AnnSVP & CHIEF BUSINESS OFFICER | SSale | −3.83K | $29.20 | −$111.7K | −10.4%33.1K after | 10b5-1 |
| Nov 17, 2023 (view filing) | Nov 15-17 | 2 days | Coen Stacy AnnSVP & CHIEF BUSINESS OFFICER | SSale | −108.6K | $16.04 | −$1.74M | −74.6%37.0K after | 3 lots10b5-1 |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | Coen Stacy AnnSVP & CHIEF BUSINESS OFFICER | SSale | −100.2K | $14.20 | −$1.42M | −90.1%11.0K after | |
| Aug 4, 2023 (view filing) | Aug 2-4 | 2 days | Coen Stacy AnnSVP & CHIEF BUSINESS OFFICER | SSale | −84.6K | $17.10 | −$1.45M | −88.5%11.0K after | 2 lots |